Biogen/ US09062X1037 /
| 5/12/2025 9:59:58 PM | Chg. +6.23 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 124.39USD | +5.27% | 19,960 Turnover: 2.48 mill. |
-Bid Size: - | -Ask Size: - | 18.23 bill.USD | - | 11.10 |
Assets
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 3,411.5000 | 3,416.4000 | 3,298.6000 | 3,309.7000 | 3,181.3000 | ||||||
| Intangible Assets | 3,084.3000 | 2,221.3000 | 1,850.1000 | 8,363 | 9,691.2000 | ||||||
| Long-Term Investments | 772.1000 | 892 | 705.7000 | 0.0000 | - | ||||||
| Fixed Assets | 17,731.8000 | 16,020.8000 | 14,762.9000 | 19,985.5000 | 20,592.5000 | ||||||
| Inventories | 1,068.6000 | 1,351.5000 | 1,344.4000 | 2,527.4000 | 2,460.5000 | ||||||
| Accounts Receivable | 1,913.8000 | 1,549.4000 | 1,705 | 1,664.1000 | 1,404.8000 | ||||||
| Cash and Cash Equivalents | 1,331.2000 | 2,261.4000 | 3,419.3000 | 1,049.9000 | 2,375 | ||||||
| Current Assets | 6,887.1000 | 7,856.5000 | 9,791.2000 | 6,859.3000 | 7,456.8000 | ||||||
| Total Assets | 24,618.9000 | 23,877.3000 | 24,554.1000 | 26,844.8000 | 28,049.3000 | ||||||
Liabilities
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 454.9000 | 589.2000 | 491.5000 | 403.3000 | 424.2000 | ||||||
| Long-term debt | 7,426.2000 | 6,274 | 6,281 | 6,788.2000 | 4,547.2000 | ||||||
| Liabilities to Banks | 7,426.2000 | 6,274 | - | - | - | ||||||
| Provisions | 1,174.8000 | 869.2000 | - | - | - | ||||||
| Liabilities | 13,932.8000 | 12,917.6000 | 11,165.7000 | 12,045.4000 | 11,333.3000 | ||||||
| Share Capital | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
| Total Equity | 10,686.1000 | 10,959.7000 | 13,388.4000 | 14,799.4000 | 16,716 | ||||||
| Minority Interests | -14.2000 | 63.5000 | -9.5000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 24,618.9000 | 23,877.3000 | 24,554.1000 | 26,844.8000 | 28,049.3000 | ||||||
Income Statement
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 13,444.6000 | 10,981.7000 | 10,173.4000 | 9,835.6000 | 9,675.9000 | ||||||
| Depreciation (total) | 457.2000 | 487.7000 | 518.4000 | 494.8000 | 673.2000 | ||||||
| Operating Result | 4,550.1000 | 2,840.7000 | - | - | - | ||||||
| Interest Income | -180.5000 | -242.6000 | -157.3000 | -29.6000 | - | ||||||
| Income Before Taxes | 5,047.5000 | 1,745.2000 | 3,591.8000 | 1,296.8000 | 1,906 | ||||||
| Income Taxes | 992.3000 | 52.5000 | 632.8000 | 135.3000 | 273.8000 | ||||||
| Minority Interests Profit | 59.9000 | 171.5000 | -85.3000 | .4000 | 0.0000 | ||||||
| Net Income | 4,000.6000 | 1,556.1000 | 3,046.9000 | 1,161.1000 | 1,632.2000 | ||||||
Per Share
Cash Flow
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 4,229.8000 | 3,639.9000 | 1,384.3000 | 1,547.2000 | 2,875.5000 | ||||||
| Cash Flow from Investing Activities | -608.6000 | -563.7000 | 1,576.6000 | -4,101 | -799.2000 | ||||||
| Cash Flow from Financing | -5,272.7000 | -2,086.2000 | -1,747.3000 | 149.3000 | -683.5000 | ||||||
| Decrease / Increase in Cash | -1,651.5000 | 990 | 1,213.6000 | -2,404.5000 | 1,392.8000 | ||||||
| Employees | 9,100 | 9,610 | - | - | - | ||||||
